Evidence map›Paper›PMID 30745462›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Hypersensitive IFN Responses in Lupus Keratinocytes Reveal Key Mechanistic Determinants in Cutaneous Lupus.

Lam C Tsoi, Grace A Hile, Celine C Berthier, Mrinal K Sarkar, Tamra J Reed, Jianhua Liu, Ranjitha Uppala, Matthew Patrick, Kalpana Raja, Xianying Xing and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Lam C TsoiDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0003-1627-5722
Grace A HileDivision of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0002-3629-8633
Celine C BerthierDivision of Nephrology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109; and.
Mrinal K SarkarDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0001-8505-4259
Tamra J ReedDivision of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109.
Jianhua LiuDivision of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109.
Ranjitha UppalaDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.
Matthew PatrickDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0002-6174-9002
Kalpana RajaDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.
Xianying XingDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.
Enze XingUniversity of Michigan Medical School, University of Michigan, Ann Arbor, MI 48109.
Kevin HeDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109.
Johann E GudjonssonDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.
J Michelle KahlenbergDivision of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109; mkahlenb@med.umich.edu.ORCID 0000-0002-4006-8945
University of Michigan · US

Funding

University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROSIUS, FRANK C · 2008 to 2022
$12.9M
University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDRZEJ A. DLUGOSZ · 2019 to 2026
$6.6M
TRAINING PROGRAM IN CELL AND MOLECULAR DERMATOLOGYT32AR007197 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAMES TILFORD ELDER, Sunny Y Wong · 1986 to 2026
$4.2M
Role of the sex biased transcription factor VGLL3 in promoting autoimmune responses in SLER01AI130025 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2017 to 2026
$3.9M
Characterization of Interferon Kappa as a Novel Target in Cutaneous LupusR01AR071384 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joanne Michelle Kahlenberg · 2017 to 2026
$3.6M
Role of IL-13 and the IL-13 Associated rs20541 Risk Variant in the Pathogenesis of PsoriasisR01AR069071 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUDJONSSON, JOHANN ELI · 2015 to 2019
$2.1M
The Role of Innate Immunity in Systemic and Cutaneous LupusK08AR063668 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAHLENBERG, JOANNE MICHELLE · 2013 to 2017
$736k
Integrative Biology Approach to Identify and Characterize Roles of lncRNAs Associated with Psoriasis PathologyK01AR072129 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TSOI, LAM CHEUNG · 2017 to 2021
$500k
Understanding Transcriptional Connections between Cutaneous and Systemic LupusR03AR066337 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAHLENBERG, JOANNE MICHELLE · 2014 to 2016
$233k
NIAID NIH HHS R01 AI130025NIAMS NIH HHS K01 AR072129NIAMS NIH HHS K08 AR063668NIAMS NIH HHS P30 AR075043NIAMS NIH HHS R01 AR069071NIAMS NIH HHS R01 AR071384NIAMS NIH HHS R03 AR066337NIAMS NIH HHS T32 AR007197NIDDK NIH HHS P30 DK081943
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which 70% of patients experience disfiguring skin inflammation (grouped under the rubric of cutaneous lupus erythematosus [CLE]). There are limited treatment options for SLE and no Food and Drug Administration-approved therapies for CLE. Studies have revealed that IFNs are important mediators for SLE and CLE, but the mechanisms by which IFNs lead to disease are still poorly understood. We aimed to investigate how IFN responses in SLE keratinocytes contribute to development of CLE. A cohort of 72 RNA sequencing samples from 14 individuals (seven SLE and seven healthy controls) were analyzed to study the transcriptomic effects of type I and type II IFNs on SLE versus control keratinocytes. In-depth analysis of the IFN responses was conducted. Bioinformatics and functional assays were conducted to provide implications for the change of IFN response. A significant hypersensitive response to IFNs was identified in lupus keratinocytes, including genes (

Indexed as

AdultFemaleGene Expression RegulationHumansInterferonsKeratinocytesLupus Erythematosus, CutaneousMalePaired Box Transcription Factorshomeobox protein PITX1InterferonsPaired Box Transcription Factors

Identifiers

PMID30745462
PMCPMC6424612
OpenAlexW2912794735

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.